1887

n Southern African Journal of HIV Medicine - Antiretroviral therapy during the neonatal period : guidelines

Volume 16, Issue 1
  • ISSN : 1608-9693
  • E-ISSN: 2078-6751
USD

 

Abstract


Initiation of combination antiretroviral therapy (cART) at 6-9 weeks of age has been shown to reduce early infant mortality by 76% and HIV progression by 75% compared with cART deferred until clinical or CD4 criteria were met. In the landmark Children with HIV Early Antiretroviral Therapy (CHER) trial, although the median age of starting cART in the early treatment arm was 7.4 weeks, one-third (10/30) of the overall mortality in the trial occurred in the early treatment arm. In another study, 62% of 403 infants who initiated cART at median 8.4 weeks of age already had advanced HIV disease (CD4 < 25% or < 1500 cells/mm3 or World Health Organization [WHO] Stage 3 or 4) at initiation.

Loading full text...

Full text loading...

Loading

Article metrics loading...

/content/m_sajhiv/16/1/EJC169832
2015-04-01
2017-11-24

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error